Axsome Therapeutics AXSM Other Inventory Noncurrent
Other Inventory Noncurrent at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherInventoryNoncurrent.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's other inventory noncurrent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's other inventory noncurrent?
- Axsome Therapeutics (AXSM) reported other inventory noncurrent of $30.83M in Q1 2026.
- How has Axsome Therapeutics's other inventory noncurrent changed year-over-year?
- Axsome Therapeutics's other inventory noncurrent increased by 49.6% year-over-year, from $20.61M to $30.83M.
- What is the long-term trend for Axsome Therapeutics's other inventory noncurrent?
- Over 4 years (2021 to 2025), Axsome Therapeutics's other inventory noncurrent has grown at a 201.9% compound annual growth rate (CAGR), from $322.91K to $26.84M.
- What does other inventory noncurrent mean?
- Inventory that is not expected to be used or sold within the next year.
- How do you interpret other inventory noncurrent?
- Holding significant non-current inventory may indicate long-term supply chain planning or potential risks of product expiration.
- How does other inventory noncurrent compare across companies?
- Rare in most industries; specific to companies with long-lead-time production or strategic supply requirements.